Canyon Pharmaceuticals Honored with Frost & Sullivan Award for Product Differentiation Excellence in Parenteral Anticoagulants
The Frost & Sullivan 2011 Product Differentiation Excellence Award in Parenteral Anticoagulants recognizes Canyon Pharmaceuticals Group AG for the development and launch of Iprivask® (desirudin for injection).
Abbott in Allschwil (BL) wins Tell Award
Abbott in Allschwil (BL) wins one of the Tell Awards 2010 of the Swiss Embassy in the US.
Iris Welten devient la nouvelle directrice de BaselArea
L’Assemblée des membres de BaselArea a nommé Iris Welten comme nouvelle directrice de BaselArea. Madame Welten détient la double nationalité allemande et suisse et jouit de quatorze ans d’expérience professionnelle qu’elle a...
FDA approves Zelboraf (vemurafenib) and companion diagnostic for BRAF mutation-positive metastatic melanoma, a deadly form of skin cancer
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma, found in half of melanoma patients, live longer.
Generous Eckenstein-Geigy Foundation facilitates research in paediatric medicine
The Eckenstein-Geigy Foundation is sponsoring the urgently needed research and development of medicines for children and adolescents to the tune of 15 million francs. For ten years initially an Eckenstein-Geigy Research Professor...